|
Your Bextra Lawyer - Vioxx, Celebrex & Bextra FDA Transcript
Your Bextra lawyer provides you the complete transcript of the February 17th, 2005 joint meeting of the FDA's Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee. We have formatted the complete transcript of the three day conference for easy of navigation to provide you with the best possible Bextra information. To contact a Bextra Lawyer, click here for a FREE case evaluation.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH JOINT MEETING OF THE
ARTHRITIS ADVISORY COMMITTEE AND THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY
COMMITTEE
VOLUME II
Thursday, February 17, 2005, 8:00 a.m
Hilton
Gaithersburg
620 Perry Parkway
Gaithersburg, Maryland
PARTICIPANTS:
Alastair J.J. Wood, M.D., Chair
Kimberly
Littleton Topper, M.D. Executive Secretary
Weitz & Luxenberg is no longer accepting Bextra cases.
see also:
Lumiracoxib, Naproxen
Your Bextra Side Effects Lawyer - Vioxx, Celebrex & Bextra FDA - Lumiracoxib, NaproxenBextra side effects lawyer - the complete transcript of the FDA meeting
Questions
Your Bextra Side Effects Lawyer - Vioxx, Celebrex & Bextra FDA - QuestionsBextra side effects lawyer - the complete transcript of the FDA meeting
FDA Transcript - Day 2
Vioxx, Celebrex & Bextra FDA TranscriptYour lawyer provides the complete transcript of the FDA meeting.
